Md. biotech industry celebrates successes, warns of challenges

Amid hopes for cures to chronic illnesses like diabetes and HIV, Maryland life science companies and their boosters wondered Monday what it will take to make the state No. 1 for cell and gene therapies. At the Maryland Life Sciences Bioinnovation Conference, leaders touted successes and announced next steps towards long-awaited cures. But they also pondered stubborn issues like access to capital and attracting strong executive teams. (Daily Record)

Read Full Article